INSIGHTS ON SOLID DOSE MANUFACTURING

• Innovations In Orally Disintegrating Tablets For Pediatric Drug Delivery

  Delve into the evolving landscape of pediatric dosage forms, with a focus on how ODTs are emerging as a specialized and practical drug delivery system for children.

• Seamless Commercial Tech Transfers In OSD Manufacturing

  A structured approach to OSD tech transfer, from NPI through PPQ and CPV, can compress timelines significantly, as one case study illustrates with full PPQ completion in under six months.

• Powder Rheology: Gateway For Tablet Sticking Insights

  Powder rheology offers a scientific method to predict and mitigate tablet sticking issues, helping to ensure smoother pharmaceutical production cycles through early material and tooling selection.

• Segments: Next-Generation Tablet Press Technology

  Segments increase press output by up to 25% and cut setup time by 88%. Learn the benefits, drawbacks, and manufacturing needs of this rapidly growing tablet press technology.

• Overcoming The Obstacles Of Spray-Dried Dispersion Scale-Up

  9/9/2026

  SDD scale-up introduces scale-dependent risks that threaten bioavailability, stability, and manufacturability. This white paper details a model-based framework for managing those risks from early feasibility through commercial production.

• Contract Pharma 2026: Mikart On CDMO Collaboration

  4/30/2026

  An overview of a milestone pharmaceutical outsourcing conference focused on CDMO collaboration, tech transfer, and oral solid and liquid dose manufacturing strategies.

   

• An Alternative Method Of Drug-Excipient Characterization

  12/30/2024

  Isothermal microcalorimetry (IMC) rapidly screens API-excipient compatibility, detecting physical and chemical interactions faster than conventional methods, saving time and effort in pharmaceutical formulation development.

• Advancing Patient-Centric Drug Delivery For Neurodegenerative Disease With Orally Dissolving Tablets

  1/27/2025

  Pharmaceutical companies must prioritize patient-centric dosage forms to address challenges like dysphagia, enhance medication compliance, and improve therapeutic outcomes.

• Safety First: Considerations When Formulating High Potency Compounds

  9/23/2026

  Developing highly potent APIs comes with unique challenges. Explore strategies for managing risk, protecting personnel, and advancing programs with confidence.